The AI-based Tumor Board: A Multi-agent approach to finding cancer treatments with AI.
Every week, 30 of Europe’s leading experts in Leukemia and Lymphoma gather online for the International Leukemia/Lymphoma Tumor Board (iLTB). Their mission is crucial: to tackle some of the most complex and treatment-resistant pediatric leukemia and lymphoma cases across Europe. This multidisciplinary team is composed of specialists in immunotherapy, genetics, molecular biology, clinical trials, and…